A Study of the Beta-blocker Propranolol Alone and With Chemotherapy in Patients Receiving Neoadjuvant Treatment for Newly Diagnosed Breast Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 11 Apr 2019
At a glance
- Drugs Propranolol (Primary) ; Cyclophosphamide; Doxorubicin; Paclitaxel; Pertuzumab; Taxanes; Trastuzumab
- Indications Breast cancer
- Focus Adverse reactions; Biomarker
- 28 Mar 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 31 Aug 2018 Biomarkers information updated
- 11 Dec 2017 Planned End Date changed from 1 Oct 2017 to 1 Dec 2018.